Dermavant Sciences

Home » Dermavant Sciences

IPO

Dermavant Sciences

Biopharmaceutical

We are a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in medical dermatology.

Symbol

DRMT

Price Range
$12.00 - $14.00

Final Shares
7,700,000

Anticipated Date
June 20, 2019

Underwriters
JEFFERIES LLC,LEERINK SWANN & COMPANY

This offering is no longer available

To view the prospectus for Dermavant Sciences IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253